Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Acute Renal Failure Article
This is a selection made from among articles on Drug Treatment Acute Renal Failure. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Looking for a Gay Drug Rehab or Alcohol Rehab in Florida
By Jonathan Huttner
For years, drug rehab programs and alcohol rehab programs have been opening in Florida. Everything from detox to inpatient addiction treatment and extended or long term care are available for the general public. There have been drug rehab programs for eating disorders, sexual trauma, men and women, but very few drug rehab programs for the gay and lesbian population. Even today, there are only a handful of drug rehab programs that specialize in gay drug rehab or gay addiction treatment and a few more with specialized gay drug rehab components within the actual drug rehab. While there are many more drug rehab programs with gay a component then true gay drug rehab programs, not many of them have staff trained in issues specific to the gay population. Issues such as homophobia, internalized homophobia, coming out and sexuality often go untouched, not to mention, the sensitivity training that must take place for the other members of the staff.
Certain areas more sensitive to Gay Drug Rehab and Gay Alcohol Rehab
I think it is safe to say there are certain areas in the state of Florida that are more sensitive to the gay, lesbian community than others. Some of the areas might include Miami, Fort Lauderdale, Orlando, Tampa and Jacksonville. Each of these cities have substantial gay populations and services to match. It stands to reason that opening a drug rehab with a gay addiction treatment component or a gay drug rehab in these areas might be easier to manage due to the community support and ancillary community services
Jacksonville Florida Drug Rehab Opens Gay Addiction Treatment Component
For as long as anyone can remember, there has not been any drug rehab programs with gay drug rehab components in Jacksonville providing addiction treatment services to the gay and lesbian community. This statement is especially true when we speak of gay drug rehab programs. What is sad is that within the Orlando, St. Augustine, Jacksonville area there is a significant gay, lesbian population. We are happy to report that a drug rehab has opened a gay component within its addiction treatment program called Freedom Rings, which can be found at www.lakeviewfreedomrings.com This may be the beginning of a trend in Northeast Florida to begin paying more attention to treating drug addiction and alcoholism within the gay and lesbian community.
Jonathan Huttner is one of the principal partners for Lakeview Health Systems, http://www.lakeviewhealth.com a drug rehab specializing in the treatment of drug addiction, alcoholism and dual diagnosis.
Article Source: http://EzineArticles.com/?expert=Jonathan_Huttner
http://EzineArticles.com/?Looking-for-a-Gay-Drug-Rehab-or-Alcohol-Rehab-in-Florida&id=362271
Drug Treatment Acute Renal Failure Specific links
Drug Treatment Acute Renal Failure News
DC Week: FDA User Fee Bill Gets Senate OK - MedPage Today
 MedPage Today | DC Week: FDA User Fee Bill Gets Senate OK MedPage Today ... against expanding the marketing indications for the factor Xa inhibitor rivaroxaban (Xarelto) to include treatment of acute coronary syndrome (ACS). The Wednesday vote by the Cardiovascular and Renal Drugs Advisory Committee was somewhat surprising ... |
Understanding, Treating Chronic Kidney Disease - VetPracticeNews.com
 VetPracticeNews.com | Understanding, Treating Chronic Kidney Disease VetPracticeNews.com “There are acute insults that destroy enough renal parenchyma in an irreversible manner and result in decreased functional renal mass,” Dr. Ishak says, citing leptospirosis, pyelonephritis, lilly intoxication, ethylene glycol intoxication, ... |
FDA Panel Narrowly Rejects Xarelto for ACS - MedPage Today
 WWLP 22News | FDA Panel Narrowly Rejects Xarelto for ACS MedPage Today ... with one abstention, against expanding the marketing indications for the factor Xa inhibitor rivaroxaban (Xarelto) to include treatment of acute coronary syndrome (ACS). The vote by the Cardiovascular and Renal Drugs Advisory Committee was somewhat ... Live Blog: The FDA Advisory Panel For Rixaroxaban for ACS |
FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits ... - MarketWatch (press release)
FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits ... MarketWatch (press release) NxStage Medical, Inc. (NASDAQ:NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of ESRD and acute kidney failure. |
FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits ... - PR Newswire (press release)
FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits ... PR Newswire (press release) NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of ESRD and acute kidney failure. |
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients ... - MarketWatch (press release)
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients ... MarketWatch (press release) The Resolute Integrity DES was approved by the US Food and Drug Administration (FDA) in February 2012 with a first-of-its-kind indication for CAD patients who also have diabetes. Research shows that people with diabetes have a two- to three-fold ... |
Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... - MarketWatch (press release)
Pfizer Provides Topline Results From Phase 3 Study Of Torisel(R) As Second ... MarketWatch (press release) TORISEL remains an important drug for treatment of advanced kidney cancer based on its pivotal study in first-line patients with poor prognostic risk," said Dr. Mace Rothenberg, senior vice president of clinical development and medical affairs for ... |
Abbott Pays Action $110M for Global Rights to Phase II-Stage Acute Kidney ... - Genetic Engineering News
Abbott Pays Action $110M for Global Rights to Phase II-Stage Acute Kidney ... Genetic Engineering News Abbott is paying Denmark's Action Pharma $110 million for global rights to develop and commercialize the latter's AP214, a Phase II-stage alpha-MSH peptide derivative currently in development for preventing acute kidney injury associated with major ... |
New Study Shows Patients Can Effectively be Switched to Latuda(R) (lurasidone ... - MarketWatch (press release)
New Study Shows Patients Can Effectively be Switched to Latuda(R) (lurasidone ... MarketWatch (press release) Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. The management of NMS should include: 1) immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent ... |
Latuda(R) (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ... - MarketWatch (press release)
Latuda(R) (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ... MarketWatch (press release) ... and acute renal failure. The management of NMS should include: 1) immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy; 2) intensive symptomatic treatment and medical monitoring; and 3) treatment of ... |